Monitor your blood pressure regularly
In individuals with T2DM, the risk of fractures was assessed using a network meta-analysis and systematic review to determine the relationship between dipeptidyl peptidase-4 inhibitors (DPP-4i), GLP-1 RAs, and sodium-glucose cotransporter-2 inhibitors (SGLT-2i)
Both medications have a glucose-dependent action, meaning they work primarily when blood sugar levels are elevated, which reduces the risk of hypoglycaemia when used alone
-24% body weight documented over 24 weeks in Phase 2 trials
Should I be concerned if I have nausea but no weight loss in week one
Individuals who cannot access GLP-1 medications due to cost, insurance limitations, or coverage denials may turn to supplements as a more accessible alternative